Inventor · disambiguated record
Ryan Erik Holcomb
Also filed as: HOLCOMB RYAN · HOLCOMB RYAN E · HOLCOMB RYAN ERIK
17 granted patents·7 pending applications·29 citations·filing 2011–2024
91Inventor score
Files withSHIRE VIROPHARMA INC7KINIKSA PHARMACEUTICALS LTD5LEVO THERAPEUTICS INC4ACADIA PHARM INC2VIROPHARMA BIOLOGICS LLC2
Top patents by PatentIndex Score
24 records- 0194US10080788B2C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiencySHIRE VIROPHARMA INC·Filed 2017·Granted Sep 25, 2018·4 cites·30 claims
- 0294US9616111B2C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiencySHIRE VIROPHARMA INC·Filed 2015·Granted Apr 11, 2017·12 cites·18 claims
- 0391US10201595B2C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiencySHIRE VIROPHARMA INC·Filed 2017·Granted Feb 12, 2019·2 cites·30 claims
- 0491US10130690B2C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiencySHIRE VIROPHARMA INC·Filed 2017·Granted Nov 20, 2018·2 cites·29 claims
- 0591US10105423B2C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiencySHIRE VIROPHARMA INC·Filed 2017·Granted Oct 23, 2018·2 cites·29 claims
- 0687US11364288B2C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiencyVIROPHARMA BIOLOGICS LLC·Filed 2019·Granted Jun 21, 2022·1 cites·8 claims
- 0785US2025114449A1Stable anti-osmr antibody formulationKINIKSA PHARMACEUTICALS LTD·Filed 2024·Application pending·0 cites
- 0882US2024091302A1Carbetocin drug product and process for preparing sameACADIA PHARM INC·Filed 2023·Application pending·0 cites
- 0979US10024797B2Biosensing systems for measurement of lactoseREARDON KENNETH F·Filed 2011·Granted Jul 17, 2018·4 cites·25 claims
- 1078US12491234B2Methods and compositions comprising surfactant protein D (SP-D)AIRWAY THERAPEUTICS INC·Filed 2019·Granted Dec 9, 2025·1 cites·22 claims
- 1178US11844764B2Agitation process for preparing a carbetocin drug productACADIA PHARM INC·Filed 2022·Granted Dec 19, 2023·0 cites·9 claims
- 1274US11534482B2C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiencyVIROPHARMA BIOLOGICS LLC·Filed 2018·Granted Dec 27, 2022·0 cites·35 claims
- 1374US11298399B2Carbetocin drug product and process for preparing sameLEVO THERAPEUTICS INC·Filed 2021·Granted Apr 12, 2022·0 cites·16 claims
- 1474US11141479B2Stable anti-OSMR antibody formulationKINIKSA PHARMACEUTICALS LTD·Filed 2019·Granted Oct 12, 2021·0 cites·19 claims
- 1574US2019160158A1C1-inh compositions and methods for the prevention and treatment of disorders associated with c1 esterase inhibitor deficiencySHIRE VIROPHARMA INC·Filed 2018·Application pending·0 cites
- 1673US11229702B1High concentration formulations of adalimumabCOHERUS BIOSCIENCES INC·Filed 2016·Granted Jan 25, 2022·1 cites·15 claims
- 1773US11207373B2Agitation process for preparing a carbetocin drug productLEVO THERAPEUTICS INC·Filed 2019·Granted Dec 28, 2021·0 cites·15 claims
- 1873US2022062414A1Stable Anti-OSMR Antibody FormulationKINIKSA PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 1971US2023201300A1Stable intranasal formulations of carbetocinLEVO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2069US2017224788A1C1-inh compositions and methods for the prevention and treatment of disorders associated with c1 esterase inhibitor deficiencySHIRE VIROPHARMA INC·Filed 2017·Application pending·0 cites
- 2168US10493149B2Stable anti-OSMR antibody formulationKINIKSA PHARMACEUTICALS LTD·Filed 2018·Granted Dec 3, 2019·0 cites·19 claims
- 2267US10391170B2Stable anti-OSMR antibody formulationKINIKSA PHARMACEUTICALS LTD·Filed 2018·Granted Aug 27, 2019·0 cites·16 claims
- 2367US2020093884A1Stable intranasal formulations of carbetocinMANNING MARK C·Filed 2019·Application pending·0 cites
- 2462US10967040B2Methods of treating prader-willi syndrome with carbetocinLEVO THERAPEUTICS INC·Filed 2020·Granted Apr 6, 2021·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Ryan Erik Holcomb files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →